GE Health Care has partnered with radiotherapy company Elekta to develop new software that improves doctors’ experience and enables more precise treatment.
Elekta will use GE HealthCare’s MIM software image management platform, which GE HealthCare purchased earlier this month. MIM’s automated contouring and treatment management platform will enable Elekta to develop radiation oncology treatments.
“Our decision to join GE HealthCare was driven by a ‘shared vision of maximizing impact’ and our motivation for this collaboration with Elekta is no different,” Andy Nelson, CEO of MIM Software, GE HealthCare, said in a statement.
“For decades, we have collaborated directly with physicians to understand their needs and close the gap by creating solutions that streamline their clinical workflows and reduce delays in patient treatment. With the evolution of treatment planning software, we can have an impact on doctors and patients around the world. “Now, we are excited to expand the reach of these efforts by powering Elekta’s offerings with our vendor-agnostic solutions.”
THE BIGGEST TREND
The new collaboration arrives just a few weeks later. GE HealthCare acquired Cleveland-based MIM Software, which provides remote software solutions for oncology, nuclear medicine, cardiac imaging and neuroimaging.
GE HealthCare has collaborated with several oncology companies over the past year. In September, the Chicago-based company partnered with Mayo Clinic to advance theranostics, artificial intelligence and digital health platforms.
theranostic is a form of precision medicine that combines diagnostic biomarkers with therapies to identify and attack cancer cells.
In In November, GE HealthCare and Grand Rapids-based BAMF Health collaborated to advance the use of theranostics. BAMF Health offers molecular therapies for people living with cancer with a strong focus on theranostics.
Last week, GE HealthCare announced that it would partner with tech giants Microsoft and LG Electronics to support the construction of smart hospitals in South Korea. The three companies signed an agreement to help hospitals use their respective medical technologies and solutions.
Stockholm-based Elekta announced in Octoberhe who acquired iCAD’s Xoft business. The electronic brachytherapy system, called Axxent Electronic Brachytherapy (eBx), uses low-energy x-rays as a source instead of radioactive isotopes, allowing the technology to be used in more clinical settings.